Please assess the completion status of the following clinical trial:

Trial Title: Phase III Study Comparing 3D Conformal Radiotherapy and Conformal Radiotherapy IMRT to Treat Endometrial Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* endometrial adenocarcinoma histologically proven~* post op pelvic radiotherapy~* age ≥ 70~* performance status ≤ 2~* MMSE ≥ 10~* life expectancy ≥ 3 months~* social security covered~* signed informed consent~Exclusion Criteria:~* type I stade IAGI and stade IAGIII without myometer infiltration, stade IIIc2 and IV adenocarcinoma~* uterine sarcoma~* surgery not in accordance with recommendations of Inca~* previous uncontrolled or less than 5 years prior to diagnosis cancer~* cons-indication for radiotherapy~* diarrhea ≥ 3 per day~* pelvic lymph nodes \> 1cm not resected during staging~* previous sigmoid diverticulitis, crohn disease, systemic disease, ulcerative haemorrhagic, collagenosis, infectious peritonitis~* IMRT other than tomotherapy~* photon energy \< 10MV~* patient under guardianship

- Gender: FEMALE
- Minimum Age: 70 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 3D conformational radiotherapy (Type: ACTIVE_COMPARATOR): 25 \* 1.8 Gy in 5 weeks (=45 Gy). 3D conformational radiation
- Intensity-Modulated Radiation Therapy (Type: EXPERIMENTAL): 25 \* 1.8 Gy in 5 weeks (=45 Gy). IMRT

Based on this trial design, predict the completion outcome and termination type (if applicable).